The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
Open accessAbstract
A newly identified novel coronavirus (SARS-CoV-2) is causing pneumonia-associated respiratory syndrome across the world. Epidemiology, genomics, and pathogenesis of the SARS-CoV-2 show high homology with that of SARS-CoV. Current efforts are focusing on development of specific antiviral drugs. Therapeutic neutralizing antibodies (NAbs) against SARS-CoV-2 will be greatly important therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19). Herein, the host immune responses against SARS-CoV discussed in this review provide implications for developing NAbs and understanding clinical interventions against SARS-CoV-2. Further, we describe the benefits, challenges and considerations of NAbs against SARS-CoV-2. Although many challenges exist, NAbs still offer a therapeutic option to control the current pandemic and the possible re-emergence of the virus in the future, and their development therefore remains a high priority.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341
Hui, D. S., I Azhar, E., Madani, T. A., Ntoumi, F., Kock, R., Dar, O., Ippolito, G., Mchugh, T. D., Memish, Z. A., Drosten, C., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.01.009 · Cited by 3,809
Xu, X., Chen, P., Wang, J., Feng, J., Zhou, H., Li, X., Zhong, W., & Hao, P. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1637-5 · Cited by 2,205
Coronavirus envelope protein: current knowledge
Schoeman, D., & Fielding, B. C. (2019) · Virology Journal · doi:10.1186/s12985-019-1182-0 · Cited by 2,074
Xie, X., Zhong, Z., Zhao, W., Zheng, C., Wang, F., & Liu, J. (2020) · Radiology · doi:10.1148/radiol.2020200343 · Cited by 1,960 · cited 1×
“COVID-19 can be diagnosed by either clinical CT radiography or a laboratory real time Reverse Transcription-Polymerase Chain Reaction (RT-PCR) [4].”
BackgroundTherapeutic options for the 2019 novel coronavirus (2019-nCoV)
Li, G., & De Clercq, E. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00016-0 · Cited by 1,729
Tian, X., Li, C., Huang, A., Xia, S., Lu, S., Shi, Z., Lu, L., Jiang, S., Yang, Z., Wu, Y., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1729069 · Cited by 1,252
Use of convalescent plasma therapy in SARS patients in Hong Kong
Cheng, Y., Wong, R., Soo, Y. O. Y., Wong, W. S., Lee, C. K., Ng, M. H. L., Chan, P., Wong, K. C., Leung, C. B., & Cheng, G. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1271-9 · Cited by 958
Liu, L., Wei, Q., Lin, Q., Fang, J., Wang, H., Kwok, H., Tang, H., Nishiura, K., Peng, J., Tan, Z., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.123158 · Cited by 830
Traggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M. R., Murphy, B. R., Rappuoli, R., & Lanzavecchia, A. (2004) · Nature Medicine · doi:10.1038/nm1080 · Cited by 697
Wong, S. K., Li, W., Moore, M. J., Choe, H., & Farzan, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300520200 · Cited by 694
[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].
Chen, L., Liu, H., Liu, W. Y., Liu, J., Liu, K., Shang, J., Deng, Y., & Wei, S. (2020) · PubMed · doi:10.3760/cma.j.issn.1001-0939.2020.0005 · Cited by 693
Liu, J., Zheng, X., Tong, Q., Li, W., Wang, B., Sutter, K., Trilling, M., Lu, M., Dittmer, U., & Yang, D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25709 · Cited by 620
ter Meulen, J., van den Brink, E. N., Poon, L. L. M., Marissen, W. E., Leung, C. S. W., Cox, F., Cheung, C. Y., Bakker, A. Q., Bogaards, J. A., van Deventer, E., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030237 · Cited by 612
Sui, J., Li, W., Murakami, A., Tamin, A., Matthews, L. J., Wong, S. K., Moore, M. J., Tallarico, A. S. C., Olurinde, M., Choe, H., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307140101 · Cited by 550
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
The PREVAIL II Writing Group (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1604330 · Cited by 520
Disappearance of Antibodies to SARS-Associated Coronavirus after Recovery
Cao, W.-C., Liu, W., Zhang, P.-H., Zhang, F., & Richardus, J. H. (2007) · New England Journal of Medicine · doi:10.1056/nejmc070348 · Cited by 367
Jiang, S., Du, L., & Shi, Z. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1723441 · Cited by 330
Kruse, R. L. (2020) · F1000Research · doi:10.12688/f1000research.22211.1 · Cited by 311
Profile of Specific Antibodies to the SARS-Associated Coronavirus
Li, G., Chen, X., & Xu, A. (2003) · New England Journal of Medicine · doi:10.1056/nejm200307313490520 · Cited by 307
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies
Zhu, Z., Chakraborti, S., He, Y., Roberts, A., Sheahan, T., Xiao, X., Hensley, L. E., Prabakaran, P., Rockx, B., Sidorov, I. A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701000104 · Cited by 287
SARS coronavirus and innate immunity
Frieman, M., Heise, M., & Baric, R. (2008) · Virus Research · doi:10.1016/j.virusres.2007.03.015 · Cited by 235
Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives
Klasse, P. J. (2014) · Advances in Biology · doi:10.1155/2014/157895 · Cited by 226
Kraft, C. S., Hewlett, A. L., Koepsell, S., Winkler, A. M., Kratochvil, C. J., Larson, L., Varkey, J. B., Mehta, A. K., Lyon, G. M., Friedman-Moraco, R. J., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ334 · Cited by 195
A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome
Jiang, S., Xia, S., Ying, T., & Lu, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0372-4 · Cited by 186
Woo, P. C. Y., Lau, S. K. P., Wong, B. H. L., Chan, K.-H., Chu, C.-M., Tsoi, H.-W., Huang, Y., Peiris, J. S. M., & Yuen, K.-Y. (2004) · Clinical and Vaccine Immunology · doi:10.1128/cdli.11.4.665-668.2004 · Cited by 175
Elshabrawy, H. A., Coughlin, M. M., Baker, S. C., & Prabhakar, B. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050366 · Cited by 172
Evidence for a Common Evolutionary Origin of Coronavirus Spike Protein Receptor-Binding Subunits
Li, F. (2012) · Journal of Virology · doi:10.1128/jvi.06882-11 · Cited by 165
Interferon and cytokine responses to SARS-coronavirus infection
Thiel, V., & Weber, F. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.01.001 · Cited by 160
van den Brink, E. N., ter Meulen, J., Cox, F., Jongeneelen, M. A. C., Thijsse, A., Throsby, M., Marissen, W. E., Rood, P. M. L., Bakker, A. B. H., Gelderblom, H. R., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1635-1644.2005 · Cited by 159
Greenough, T. C., Babcock, G. J., Roberts, A., Hernandez, H. J., Thomas, Jr., Coccia, J. A., Graziano, R. F., Srinivasan, M., Lowy, I., Finberg, R. W., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/427242 · Cited by 158
Understanding the T cell immune response in SARS coronavirus infection
Oh, H. J., Gan, S. K., Bertoletti, A., & Tan, Y. (2012) · Emerging Microbes & Infections · doi:10.1038/emi.2012.26 · Cited by 155
Tseng, C.-T. K., Perrone, L. A., Zhu, H., Makino, S., & Peters, C. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7977 · Cited by 153
Nie, Y., Wang, G., Shi, X., Zhang, H., Yan, Q., Zhong-ping, H., Wei, W., Lian, G., Yin, X., Du, L., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/423286 · Cited by 146
Affinity maturation of antibodies assisted by in silico modeling
Barderas, R., Desmet, J., Timmerman, P., Meloen, R. H., & Casal, J. I. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801221105 · Cited by 142
The Molecular Biology of SARS Coronavirus
Satija, N., & Lal, S. K. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1408.002 · Cited by 134
A human SARS-CoV neutralizing antibody against epitope on S2 protein
Duan, J., Yan, X., Guo, X., Cao, W., Han, W., Qi, C., Feng, J., Yang, D., Gao, G., & Jin, G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.089 · Cited by 114
Coughlin, M. M., & Prabhakar, B. S. (2011) · Reviews in Medical Virology · doi:10.1002/rmv.706 · Cited by 87
Zhao, Q., Ahmed, M., Tassev, D. V., Hasan, A., Kuo, T.-Y., Guo, H.-F., O’reilly, R. J., & Cheung, N. K. (2015) · Leukemia · doi:10.1038/leu.2015.125 · Cited by 85
Self-citationCoughlin, M., Lou, G., Martinez, O., Masterman, S. K., Olsen, O. A., Moksa, A. A., Farzan, M., Babcook, J. S., & Prabhakar, B. S. (2007) · Virology · doi:10.1016/j.virol.2006.09.029 · Cited by 70
Panesar, N. S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13557-x · Cited by 52
Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses
Prabakaran, P., Zhu, Z., Xiao, X., Biragyn, A., Dimitrov, A. S., Broder, C. C., & Dimitrov, D. S. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590902763755 · Cited by 52
Human monoclonal antibodies as candidate therapeutics against emerging viruses
Jin, Y., Lei, C., Hu, D., Dimitrov, D. S., & Ying, T. (2017) · Frontiers of Medicine · doi:10.1007/s11684-017-0596-6 · Cited by 51
Liu, L., Wei, Q., Nishiura, K., Peng, J., Wang, H., Midkiff, C. C., Alvarez, X. A., Qin, C., Lackner, A. A., & Chen, Z. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.127 · Cited by 41
Zhao, Q., Ahmed, M., Guo, H.-F., Cheung, I. Y., & Cheung, N. V. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.650903 · Cited by 38
Self-citationHost Immune Responses to SARS Coronavirus in Humans
Li, C. K.-F., & Xu, X. (2009) · Springer eBooks · doi:10.1007/978-3-642-03683-5_16 · Cited by 28
Cross-reactivity of antibody against SARS-coronavirus nucleocapsid protein with IL-11
Cheng, M. W., Chan, C. W. L., Cheung, R. C. F., Bikkavilli, R. K., Zhao, Q., Au, S. W. N., Chan, P. K. S., Lee, S. S. T., Cheng, G. Y.-M., Ho, W. K. K., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.088 · Cited by 23
Self-citationLi, D., Gong, R., Zheng, J., Chen, X., Dimitrov, D. S., & Zhao, Q. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.02.058 · Cited by 22
Self-citationHuman monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1
Zhu, Z., Prabakaran, P., Chen, W., Broder, C. C., Gong, R., & Dimitrov, D. S. (2013) · Virologica Sinica · doi:10.1007/s12250-013-3313-x · Cited by 17
Screening and expressing HIV-1 specific antibody fragments in Saccharomyces cerevisiae
Wang, Y., Shan, Y., Gao, X., Gong, R., Zheng, J., Zhang, X. D., & Zhao, Q. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.10.013 · Cited by 7
Self-citation
Cited by
Huang, Y., Yang, C., Xu, X.-F., Xu, W., & Liu, S.-W. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0485-4 · Cited by 2,224
Barnes, C. O., West, A. P., Huey-Tubman, K. E., Hoffmann, M. A. G., Sharaf, N. G., Hoffman, P. R., Koranda, N., Gristick, H. B., Gaebler, C., Muecksch, F., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.025 · Cited by 795
A Review of SARS-CoV-2 and the Ongoing Clinical Trials
Tu, Y.-F., Chien, C.-S., Yarmishyn, A. A., Lin, Y.-Y., Luo, Y.-H., Lin, Y.-T., Lai, W.-Y., Yang, D.-M., Chou, S.-J., Yang, Y.-P., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072657 · Cited by 686
Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2
Younes, N., Al-Sadeq, D. W., AL-Jighefee, H., Younes, S., Al-Jamal, O., Daas, H. I., Yassine, H. M., & Nasrallah, G. K. (2020) · Viruses · doi:10.3390/v12060582 · Cited by 410
Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review)
Calina, D., Docea, A., Petrakis, D., Egorov, A., Ishmukhametov, A., Gabibov, A., Shtilman, M., Kostoff, R., Carvalho, F., Vinceti, M., et al. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4596 · Cited by 318
Metadata
- Authors
- Zhou, G., & Zhao, Q.
- Venue
- International Journal of Biological Sciences
- Publisher
- Ivyspring International Publisher
- Published
- 2020
- Volume
- 16
- Issue
- 10
- Pages
- 1718-1723
- ISSN
- 1449-2288 (ISSN-L)
- OpenAlex
- W3012764845
- Cited by
- 266
- References
- 57
- FWCI
- 7.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.